Robitussin cough syrups recalled in the US due to microbial contamination

British healthcare company Haleon has initiated a voluntary nationwide recall of Robitussin cough syrups in the US due to microbial contamination.

In a statement on Wednesday, Haleon recalled eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult, with expiration dates from October 2025 to June 2026.

It says it has not received any reports of adverse events related to the recall.

Robitussin is advertised as a product to soothe sore throats and relieve cough and flu symptoms.

Haleon said immunocompromised individuals were at risk of serious or life-threatening side effects, such as fungemia (the presence of mold or yeast in the blood) if they used the products.

Symptoms of fungemia Involving chronic fatigue, severe confusion, non-healing and persistent lesions and wounds, unusual and irregular discharge, and sweating and itching.

Use of the products by individuals with weakened immune systems can also potentially lead to disseminated fungal infections, when a fungus spreads through the body and causes problems. included skin ulcers, abscesses, fever, bone lesions or meningitis.

For non-immunocompromised individuals, life-threatening infections are unlikely, but Haleon said that “the occurrence of an infection that may require medical intervention cannot be completely excluded.”

The company said it is directly notifying its distributors and customers and has provided them with instructions on how to return all recalled products. Customers can contact Haleon’s consumer relations team at 1-800-245-1040 or by emailing mystory.us@haleon.com.

The company added that the recall is being conducted with the knowledge of the Food and Drug Administration.

At least there have been since January four drug recalls in the US, including lubricant eye drops, various IV bags and Zenzedi or dextroamphetamine sulfate tablets, according to the FDA. Some of the reasons for the recalls included safety concerns about devices and medications, the possibility of super-strength medications, and mislabeled packaging.

Related Post